Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Procept completes phase I testing with PRO-2000 gel

Oct. 22, 1997

Aronex receives grants for development of HIV integrase inhibitor

Oct. 22, 1997

Positive results obtained with Theratechnologies' AIDS gene therapy

Oct. 21, 1997

Promising preliminary phase II data reported for VX-478/141W94

Oct. 20, 1997

HIV-infected T-cells and macrophages efficiently killed by new T-cell gene therapy

Oct. 16, 1997

PNU-140690: a novel HIV protease inhibitor in clinical testing at P&U

Oct. 14, 1997

Combined pharmacological/genetic strategy for HIV shows promise

Oct. 13, 1997

NIH approves study of marijuana in HIV-infected patients

Oct. 13, 1997

Boehringer Ingelheim presents compounds active against mutant HIV-1 RT

Oct. 9, 1997

Oligonucleotide compound in development for HIV-1 at Sankyo

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026